Description

The Department of Ophthalmology at The Johns Hopkins University seeks exceptional applicants for an Assistant Professor tenure-track faculty position in Glaucoma, possessing an expertise in Nanomedicine and Sustained Release technology. Opportunities for collaborations with several glaucoma scientists and clinician-scientists will be available and strongly encouraged. The applicant will be encouraged to interact with, and draw upon the strengths of, many centers of excellence at Wilmer including the Center for Nanomedicine, Stem Cell Ocular Regenerative Medicine (STORM), Translational Tissue Engineering (TTEC), and other divisions (retina, cornea) in which novel nanotechnology-based approaches can significantly enhance drug discovery, personalized medicine and translational work towards novel therapies. Also, significant research efforts in drug discovery (e.g. Johns Hopkins Drug Discovery) and identifying novel venues to implement and spread discovery (e.g. Center for Bioengineering Innovation and Design) are ongoing through Johns Hopkins, and would benefit from research synergy that could be an impetus for translational/commercialization efforts for societal impact.

Requirements

All applicants must hold a Ph.D. in the biochemical sciences, or biomedical engineering with demonstrated advanced specialization in the creation and/or utilization of novel biomaterials which can be used to deliver sustained drug and gene therapies for ocular and inflammatory disorders, particularly glaucoma. The recruited applicant will be expected to develop a world-class research program integrating nanomedicine, bioengineering, and eye disease, and to work diligently to become a leader in the field. Commitment to teaching excellence at the graduate levels and experience mentoring undergraduate and graduate students is required. Successful candidates will have demonstrated valuing scientific discourse, an ability to establish and maintain fruitful collaborations and procure independent funding for their research program. Women and applicants from underrepresented minority groups are encouraged to apply.